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West Nile virus (WNV) infections in vertebrates are generally acute but persistent infections have been observed. To investigate the ability of
WNV to produce persistent infections, we forced subgenomic WNV replicons to replicate within a cell without causing cell death. Detailed analyses
of these cell-adapted genomes revealed mutations within the nonstructural protein genes NS2A (D73H, M108K), NS3 (117Kins), NS4B (E249G)
and NS5 (P528H). WNV replicons andWNVs harboring a subset of NS2A or NS3 mutations showed a reduction in genome replication, a reduction
in antigen accumulation, a decrease in cytopathic effect, an increased ability to persist in cell culture and/or attenuation in vivo. Taken together, these
data indicate that WNV with a defect in replication and an increased potential to persist within the host cell can be generated by point mutations at
multiple independent loci, suggesting that persistent viruses could arise in nature.
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West Nile virus (WNV, family Flaviviridae, genus Flavi-
virus) has caused significant morbidity and/or mortality among
avian, equine and human populations in North America since
1999. Although a large number of avian and equine deaths have
been attributed to WNV infection, viral infection is typically
non-fatal for humans. Approximately 20% of infected indivi-
duals show symptoms of infection (the majority of these cases
present with a mild febrile illness characterized by malaise,
headache, altered mental condition and sometimes rash) but
neurological complications (including acute flaccid paralysis,
meningitis and encephalitis) can occur less frequently and can
result in death (Petersen and Marfin, 2002). Currently, there are
no FDA-approved vaccines to prevent disease or antiviral thera-
pies available to treat infection.Most patients mount an antibody⁎ Corresponding author. Fax: +1 409 747 8150.
E-mail address: pwmason@utmb.edu (P.W. Mason).
0042-6822/$ - see front matter © 2007 Published by Elsevier Inc.
doi:10.1016/j.virol.2007.02.009response and display a rapid and complete recovery from illness.
Thus, WNV infections are generally considered acute.
It has been suggested, however, that WNV could be capable
of causing a prolonged infection. Several other members of the
genus Flavivirus including Japanese encephalitis virus (Ravi
et al., 1993), Modoc virus (Johnson, 1970), St. Louis
encephalitis virus (Slavin, 1943) and tick-borne encephalitis
virus (Pogodina et al., 1981) have been reported to cause long-
lived or persistent infections. Hamsters (Tesh et al., 2005; Xiao
et al., 2001) and rhesus monkeys (Pogodina et al., 1983)
experimentally infected with WNV have evidence of viral
replication in their tissues months post infection. Less is known
about persistent WNV infections in humans. Anti-WNV IgM
has been detected in patients' sera over 500 days post symptom
onset (Roehrig et al., 2003) or in the central nervous system over
100 days post symptom onset (Kapoor et al., 2004). Recently, a
case of persistent WNV infection in a human patient has been
reported (Penn et al., 2006). Despite this, little is known of the
factors that influence the duration of infection.
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molecule that is translated as a single polyprotein, which is co-
and post-translationally cleaved into 10 structural (C, prM and
E) and nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A,
NS4B and NS5) (Lindenbach and Rice, 2001). The functions of
some of these proteins have been described (NS2B/NS3 is the
protease, NS3 functions as a helicase and NTPase and NS5 is
the RNA-dependent RNA-polymerase and methyltransferase)
but the exact functions of NS1, NS2A, NS4A and NS4B have
not been determined (Lindenbach and Rice, 2001). Viral
replication occurs in a replication complex associated with the
endoplasmic reticulum (ER) of infected cells, presumably
through the interaction of small hydrophobic nonstructural
proteins NS2A, NS2B, NS4A and NS4B with ER membranes,
other viral nonstructural proteins and host factors (Lindenbach
and Rice, 2001). In addition to a putative role in the assembly of
viral replication complexes, studies with WNV and other flavi-
viruses indicate that one or more of these nonstructural
proteins could play a role in altering the cell's response to
infection (Jones et al., 2005; Liu et al., 2005, 2006; Munoz-
Jordan et al., 2005; Munoz-Jordan et al., 2003; Scholle and
Mason, 2005).
WNV replicons (WNR) are genomes that lack the majority of
the structural gene sequence and are capable of self-replication.
Replicons are unable to produce infectious virions and are
therefore useful tools to study some aspects of viral replication.
WNR contain the 5′ and 3′ untranslated regions, a cyclization
sequence within the C coding sequence required for RNA
replication and all nonstructural protein genes. Several
laboratories have generated WNV and Kunjin virus (KUNV, a
subtype of WNV) replicons and these genomes tolerate the
addition of new genetic material thereby allowing reporter
genes or antibiotic resistance genes to be inserted (Khromykh
and Westaway, 1997; Rossi et al., 2005; Scholle and Mason,
2005; Shi et al., 2002). Individual cells containing replicons
harboring antibiotic resistance genes can be selected using the
appropriate antibiotic within the media and if the replicon is not
cytotoxic, replicon-bearing cells can be cloned and expanded to
produce clonally-derived cell lines. Replicon-bearing cell lines
can be used to study genome replication (Fayzulin et al., 2006;
Liu et al., 2004), the interactions between the replicon and the
cell (Fredericksen and Gale, 2006; Guo et al., 2005; Liu et al.,
2004; Rossi et al., 2005; Scholle and Mason, 2005), or as a tool
to identify anti-WNV compounds (Gu et al., 2006; Lo et al.,
2003; Rossi et al., 2005).
We previously reported that cells transfected with a WNR
encoding the neomycin phosphotransferase (NPT) gene could
form colonies under G418 antibiotic selection (Rossi et al.,
2005). In these studies, we demonstrated that three cell types
(Vero, BHK and Huh7) could successfully harbor WNRs
transiently. However, the percentage of transfected cells that
could progress to persistent infection and form colonies under
G418 selection (colony-formation efficiency or CFE) was
notably different among these cell lines. We were readily able
to obtain G418-resistant BHK and Vero cells persistently har-
boring the WNR but in Huh7 cells, the efficiency of recovering
G418-resistant cells was less than 1% (Rossi et al., 2005). Oncethese G418-resistant colonies were established they could be
maintained in the absence of G418 for weeks without loss of the
replicon, suggesting that a stable adaptation had occurred. Rep-
licon genomes harvested from one cloned G418-resistant Huh7
cell line (Huh7 cl 1.1) produced a CFE of 100%when introduced
into naïve cells, demonstrating the genetic adaptation ofWNR to
persist in cell culture (Rossi et al., 2005).
Replicon-bearing cell lines can provide data detailing specific
virus–host interactions. We showed previously that interferon-
stimulated response element (ISRE) activation was decreased in
a replicon-bearing Huh7 cell line after type I interferon (IFN)
stimulation compared to cells that were cured of the replicon
(Rossi et al., 2005). Replicon-bearing Huh7 cells also produced
less phosphorylated STAT1 after IFN treatment (Scholle and
Mason, 2005). Both Vero and Huh7 replicon-bearing cells,
however, could be cured of the replicon by adding IFN to the
culture medium (Rossi et al., 2005), indicating that these cell-
adapted replicons were not able to completely block the antiviral
action of IFN. KUNV replicons, adapted to replicate noncyto-
pathically in BHK cells, contained mutations in NS2A and NS5;
cells expressing KUNV replicons encoding one of these muta-
tions (NS2A A30P) induced higher levels of IFNβ transcription
than cells transfected with wt KUNV (Liu et al., 2004).
Additionally, KUNV NS2A A30P could not replicate in cells
capable of mounting an IFNα/β response to infection and were
attenuated in mice (Liu et al., 2006).
In this manuscript, we identify and characterize several
mutations that have been selected during the adaptation ofWNR
to persistently replicate in cell culture. Using reverse genetic
techniques, we demonstrated that a subset of these mutations
could independently produce replicons that readily persisted in
Huh7 cells. These mutations reduced the ability of WNR and
WNV genomes to replicate and produce cytopathic effect.
Viruses harboring these mutations were highly attenuated in
mice and a NS2A mutant virus produced lower viremia than the
wt WNV. Furthermore, less IFN was detected in the serum of
mice infected with this NS2A mutant than in mice infected with
wt WNV. These results demonstrate that multiple individual
mutations allowWNR to replicate to levels low enough to persist
in vitro, and suggest that similar changes could allow WNV to
persist in vivo.
Results
Replicon genomes from antibiotic-resistant cell clones encode
various independent mutations
We have previously shown that WNR NS1-5 ET2AN and
WNR NS1-5 EG2AN genomes (Fig. 1) that were adapted to
replicate in Huh7 cells have acquired mutation(s) that confer a
cell-adapted phenotype (Rossi et al., 2005). To identify these
mutations, we sequenced the complete replicon genomes
harbored within three independent WNR-bearing G418-resis-
tant Huh7 cell clones. Only a few mutations were detected in
these genomes (Fig. 2A). Sequence analysis of the 5′ and 3′
UTRs revealed no mutations in any replicon examined. In the
coding region, one synonymous (NS3 G32G), one insertion
Fig. 1. Schematic diagrams of replicon genomes used in these studies (see Materials and methods). All constructs used in this study are based on the TX02 WNV
genome (Rossi et al., 2005).
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observed. One non-synonymous mutation observed in NS4B
(E249E/G) was observed in four clones, but always as a mixed
population. Interestingly, this mixed population appeared to be
stable since it was observed after up to 41 passages in G418. The
small number of synonymous mutations within these three
replicon-bearing cultures indicates that there is a selectiveFig. 2. Position of cell-adapted mutations detected in WNR NS1-5 ET2AN present in
clone name, reporter gene and passage number at sequencing. Horizontal lines denot
genomes that were sequenced in their entirety. (B) Eight genomes that were sequence
from which the replicon was harvested. Replicons harvested from MEF cl 23.1 werepressure for specific coding changes within the replicons that
successfully adapted to Huh7 cells.
The frequency of mutations observed within the NS2A gene
was of particular interest. KUNV replicons adapted to BHK cell
cultures also showed NS2A mutations (Liu et al., 2004, 2006),
suggesting that this was a potential ‘hotspot' for the accumula-
tion of cell-adapted mutations. When additional repliconsreplicon-bearing cell lines. The left side of each panel shows parental cell line,
e regions where PCR products of harvested replicons were sequenced. (A) Five
d through the NS2A coding region only. The cell line listed indicates the cell line
adapted to MEF STAT1−/− cl2.3 (clone not sequenced) cells prior to sequencing.
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cell types were harvested and sequenced in their entirety or
across the NS2A gene, more than half of the genomes sequenced
had a mutation within the NS2A gene (Fig. 2).
Specific changes in NS2A and NS3 increase the ability of WNR
to persist in cell culture
To evaluate the influence of select individual mutations on
in vitro persistence, several mutations were selected for further
analysis (Table 1). The missense mutations from the three
replicon-bearing Huh7 cell lines that were sequenced in their
entirety were incorporated into WNR NS1-5 ET2AN (Fig. 1) by
standard reverse-genetic techniques and these genetically
engineered replicons were tested for their CFE. In Huh7 cells,
WNR NS1-5 ET2AN harboring NS2A D73H, NS2A M108K
or NS3 117Kins displayed CFEs of 100% whereas the wt
replicon had a CFE of less than 1%. Interestingly, a NS2A
A30P mutation (reported to increase antibiotic-resistant colony-
formation in KUNV replicons (Liu et al., 2004)) displayed a
CFE of 3.5% in our WNR (Table 1). The NS4B E249G and
NS5 P528H mutations produced low CFEs, very similar to wt
WNR NS1-5 ET2AN (Table 1).
There was a notable difference in the intensity of antigen
staining in cells transfected with some mutant WNR NS1-5
ET2AN. There was no detectable difference in staining intensity
among cells containing the wt, NS2A A30P, NS4B E249G or
NS5 P528H mutant replicons. However, cells transfected with
WNRs with NS2A mutations D73H and M108K or NS3
117Kins stained less intensely than cells expressing wt WNR,
suggesting that these mutations reduced WNR replication.
Among these mutants, replicons harboring the NS3 117Kins
stained most poorly and cells transfected with this WNR re-
quired amplification of the antibody signal by biotin–streptavi-
din for consistent detection.
Cell-adapted mutations reduce genome replication
To quantify the replication of WNRs bearing cell-adapted
mutations, we measured enhanced green fluorescent protein
(eGFP) fluorescence intensity in cells infected with VLPs con-
taining WNR C-eGFP-NS1-5. Fig. 3A shows histograms
depicting eGFP fluorescence intensity at 24 h post infectionTable 1
Summary of CFE for individual WNR NS1-5 ET2AN engineered to contain
specific mutations
Gene Mutation CFEa (%) Increase in
CFE over wt
wt NONE 0.75 n/a b
NS2A A30P 3.5 4.7×
NS2A D73H 100 133×
NS2A M108K 100 133×
NS3 117Kins 100 133×
NS4B E249G 1.5 2×
NS5 P528H 1.3 1.7×
a CFE=colony-formation efficiency.
b Not applicable.(hpi) of VLP-infected cells. This figure shows that in cells
infected with genomes encoding NS5 P528H (geometric mean
or GM=8561) or NS2A A30P (GM=8408) the profile of eGFP
fluorescence intensity was comparable to wt-infected cells
(GM=8489). EGFP intensity in cells infected with genomes
containing the NS4B E249Gmutation (GM=7705) was slightly
less than wt. WNR NS2A M108K (GM=2801) and NS2A
D73H (GM=3317) infected cells showed the weakest expres-
sion of eGFP, consistent with the weak antigen staining observed
in WNR NS1-5 ET2AN-transfected Huh7 cells. Results from
WNRNS3 117Kins were not reported since VLPs encoding this
mutation produced a fluorescence intensity similar to wt levels,
suggesting that a phenotypic reversion had occurred and that this
mutation was unstable under these conditions (see WNV NS3
117Kins characterization below). A reduced level of genome-
encoded eGFP fluorescence was previously noted in two WNR
NS1-5 EG2AN-bearing cell lines that were passaged 31 times in
G418-containing media compared to a cell population that was
transiently infected with the same replicon and these data
correlated with the RNA levels measured during replication
(Rossi et al., 2005).
EGFP VLP infections were also analyzed for changes in
eGFP fluorescence over time to observe the rates of WNR C-
eGFP-NS1-5 replication. Fig. 3B shows the GM eGFP
fluorescence intensity at 12, 16, 20 and 24 hpi. EGFP
fluorescence intensity increased over time in all infected
samples but more slowly for cultures infected with WNR
eGFP-NS1-5 NS2A D73H or NS2A M108K. Genomes
expressing the NS2A A30P mutation showed a lag in the
establishment of efficient genome replication but at 24 hpi,
eGFP expression were similar to wt levels (Fig. 3B).
Replicons bearing cell-adapted mutations are less cytopathic
To quantify the cytopathology produced by the WNR NS1-5
encapsidated into VLPs, Huh7 monolayers were infected
with VLPs harboring selected NS2A mutations at a multi-
plicity of infection (MOI) of 5 and monitored for cell number
using an MTT assay (Fig. 4A). The number of cells was
measured at each day for 5 days and normalized to an
uninfected control. Although no differences in cell number
were observed between the different VLP-infected cultures
for the first 4 days, cultures containing the wt and NS2A
A30P mutant showed a precipitous drop in cell number at
day 5. Moreover, cells infected with the VLPs encoding
either cell-adapted mutation NS2A D73H or NS2A M108K
appeared similar in morphology to mock-infected cells at this
time point (results not shown). When these cultures were
immunostained at day 6, nearly all of the cells were antigen-
positive (Fig. 4B), independent of the VLP they were
infected with, confirming that most of the cells were infected,
an important control since uninfected cells could confound
the results obtained within this experiment. Most uninfected
and NS2A D73H-infected cells had cellular morphology
consistent with healthy and dividing cells whereas wt or
NS2A A30P infected cells were in the process of dying
(condensed and rounded; Fig. 4B).
Fig. 3. Levels of eGFP fluorescence in cultures infected with VLPs containing
WNR C-eGFP-NS1-5 with selected cell-adapted mutations. (A) Histograms
showing eGFP fluorescence in cell populations at 24 hpi with WNR C-eGFP-
NS1-5 VLPs containing the indicated mutations. In this experiment, uninfected
cells showed a peak fluorescence intensity of approximately 66. The arrow above
each peak of eGFP-expressing cells indicates the mean geometric fluorescence
intensity of eGFP expression. (B) Time course of eGFP fluorescence intensity at
different times post infection. Both panels show data from one of three expe-
riments that showed similar trends.
Fig. 4. Survival of Huh7 cells infected with VLPs encoding selected NS2A cell-
adaptedmutations. Huh7 cells were infectedwith VLPs (harboringWNRNS1-5)
at an MOI of 5. (A) Cell number determined by MTT staining at 5 days post
infection (dpi); values are shown normalized to MTT data from mock-infected
cells. Error bars denote standard deviation. (B) Micrographs (20× magnification)
of cell monolayers from parallel cultures that were fixed 6 dpi and immuno-
stained for WNV proteins. Cultures infected with WNR NS1-5 NS2A M108K
were not fixed and stained for analysis. Arrows denote viable cells positive for
WNR antigen.
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in vitro
To evaluate the effect of cell-adapted mutations on WNV,
full-length genomes were engineered to contain these mutations
using standard molecular biology techniques. The sizes of
infectious foci produced from these viruses were dramatically
different between the wt virus and viruses harboring cell-adapted
mutations or a 3′ UTR deletion (Fig. 5A). Specifically, viruses
harboring cell-adapted mutations NS2A D73H, NS2A M108K,
3′ UTRΔ produced much smaller antigen-positive foci than the
wt virus in Vero cells at 48 hpi, whereas the NS2A A30P and
NS4B E249G produced foci in Vero cells that were slightly
smaller than the foci produced by wt virus, and the NS5 P528H
virus displayed foci indistinguishable from those produced by
the wt virus (Fig. 5A). Interesting, when a subset of these viruses
Fig. 5. Comparison of focus formation and growth of mutant and wt WNV. (A)
Vero cell monolayers infected with viruses and immunostained 2 dpi to detect
viral antigen-containing foci (see in Materials and methods). (B) Viral growth
curve of Vero and Huh7 cells infected at a MOI of 0.1 with the indicated viruses
(see Materials and methods). Samples were titrated on either Vero or Huh7
monolayers as indicated in the figure. Error bars denote the standard deviation of
the titration. The limit of detection for this assay (shown by the dotted line) was
3.3×102 ffu/ml.
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viruses formed foci identical in size to wt virus, whereas NS2A
D73H, NS2A M108K, and 3′ UTRΔ formed substantially
smaller foci (Supplemental Fig. 1). Viruses encoding the NS3
117Kins also produced large foci that were indistinguishable
from wt WNV, indicating that a phenotypic reversion had oc-
curred (results not shown). Sequence analyses of the recovered
WNV 117Kins revealed a missense mutation in the insertedresidue, which changed the K to an M. Viruses that produced
small foci also produced little CPE in cell culture. For viruses
encoding NS2A D73H, NS2A M108K or 3′ UTRΔ, little CPE
was noted in infected cultures at 72 hpi. In contrast, CPE was
readily evident in cultures infected with WNV NS2A A30P,
WNV NS4B E249G, WNV NS5 P528H and wt WNVat the 72
hpi.
Vero and Huh7 cells were used to produce growth curves for
selected viruses. Cell monolayers were infected with an MOI of
0.1 for 1 h, then washed and refed with minimal growth media
(DMEM with 20 mM HEPES 1% FBS and 1% antibiotics).
Samples of the supernatant were taken at indicated time points
and titrated on Vero or Huh7 cell monolayers (Fig. 5B). At 48
hpi, peak titers were reached for wt WNV and WNV NS2A
A30P at which point WNV NS2A A30P produced a log fewer
infectious particles than wt WNV. At 48 hpi, titers of WNV
NS2A M108K and WNV NS2A D73H were 2–3 logs lower
than wt in both cell types. By 72 hpi, peak titers had not been
attained for WNV harboring either NS2A D73H or M108K
mutations in Vero cells or for NS2A M108K infection of Huh7
cells. These findings suggest that viral replication level per se
(rather than particular mutations that alter the interaction of
mutant viruses with particular host factors) is the most important
aspect determining in vitro persistence since the growth trends
of these NS2A D73H and M108K viruses were similar between
two cell lines, even thought differences in in vitro persistence are
only observed in the Huh7 cells (see above). As mentioned
above, at 72 hpi, CPE was only evident in cells infected with wt
WNV or WNV NS2A A30P and was not present in mock-
infected cultures or cultures infected with WNV NS2A D73H
and WNV NS2A M108K.
Viruses that replicate poorly in vitro are attenuated in vivo
The virulence of mutant and wt WNVwere determined using
Swiss-Webster mice. The survival data and 50% lethal dose
(LD50) values determined for these viruses are shown in Table 2.
Viruses that showed no (or very little) reduction in replication
and CPE in vitro (harboring mutations NS2A A30P, NS4B
E249G or NS5 P528H) compared to the wt WNV were virulent
in vivo with similar LD50 values. On the other hand, viruses that
replicated poorly and caused little CPE (harboring mutations
NS2AD73H,WNVNS2AM108K orWNV3′UTRΔ) were not
virulent in mice (Table 2). These viruses did not cause death in
any infected mouse except for WNV NS2A D73H, which killed
1 out of 5 mice given 100 ffu. No mice infected with 1000 ffu of
WNV NS2A D73H, WNV NS2A M108K and WNV 3′ UTRΔ
died so LD50 values for these viruses could not be accurately
calculated from this experiment and were recorded at above
1000 ffu (Table 2).
To determine if the differences in LD50 were due to lack of
productive infection, surviving animals were tested for the
presence of antibody to WNV by neutralization assay. All mice
that survived infection with 100 ffu of the inoculated viruses
seroconverted, but those animals inoculated with the poorest
replicating virus, 3′ UTRΔ, showed lower convalescent anti-
body titers (Table 2). These results indicate that these mice were
Table 2
Summary of phenotypes and genotypes of WNV in vivo
Virus LD50
a Detailed data from 100 ffu inoculation dose
MDDb % Survival Seroconversion c Genotype d
NS2A A30P 4.2 10(1.41) 20 +++ P,P
NS2A D73H >1000 e 13(0) 80 f ++,++,+++,+++ D
NS2A M108K >1000 e n/a g 100 h +++,+++,+++,+++,+++ n/a
NS4B E249G 6.9 10.3(1.5) 20 +++ G
NS5 P528H 4.2 9.25(1.5) 20 +++ H
3′ UTRΔ >1000 e n/a 100 h +,+,++,+++,+++ n/a
wt 3.2 8.8(1.3) 0 n/a n/a
a LD50 values calculated by the Reed and Muench method for calculating 50% endpoint dilutions (Reed and Meunch, 1938) using 14-day survival data for groups
inoculated with 0.1–100 ffu, except where noted.
b Mean day of death, number in parentheses denotes standard deviation.
c Neutralization antibody titer from mice collected 1 month post inoculation (see Materials and methods). Titers of 1/320, 1/1280 and >1/2560 are denoted by +, ++
and +++, respectively.
d Amino acid sequence detected in viruses recovered from brains collected at death from one or more individuals (see Materials and methods).
e Less than 50% death in each group inoculated with 0.1–1000 ffu.
f p<0.05 compared to wt WNV by Fisher's exact test.
g Not applicable.
h p<0.01 compared to wt WNV by Fisher's exact test.
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and mount an immune antibody response.
Mutant WNV lethality was associated, in some cases, with
reversion
Mortality detected in mice infected with viruses showing a
cell-adapted phenotype was the result of phenotypic reversion.
As indicated above, no mice infected with any administered
dose of WNV NS2A M108K or WNV 3′ UTRΔ died. One
mouse died from infection with 100 ffu of WNV NS2A D73H
and, in this case, the virus reverted back to the wt genotype at
the mutated locus (Table 2), indicating that WNV NS2A D73H
has an attenuated phenotype and that reversion to the wt residue
at this position was responsible for the lethal phenotype
observed. Virus recovered from moribund mice infected with
viruses harboring NS2A A30P, NS4B E249G and NS5 P528H
showed no reversion to the wt amino acid at the mutated codon,
retaining their respective mutations (Table 2).
Mice infected with WNV NS2A D73H produce a reduced
viremia and IFN response to infection
We next sought to assess the relative levels of viral load in the
serum of mice infected with either WNV NS2A D73H or wt
WNV. Mice were infected intraperitoneally (i.p.) with 1×105
ffu of virus and serum was harvested from three animals each
day for 6 days. Mice infected with the WNV NS2A D73H
produced a lower viremia than mice infected with wtWNV (Fig.
6A). The mice infected with WNV NS2A D73H had a peak titer
on day 1-post infection that was 100× lower than wt levels, a
difference trending toward significance (t-test; p<0.06). After
day 3, no virus was detectable in mice infected withWNVNS2A
D73H. The wt-infected mice had a peak viremia at day 2 with an
average of 1×105 ffu/ml serum and lasted for 4 days. Virus was
undetectable in all mice on days 5 and 6 post infection.Serum samples were also assayed for the presence of IFN by
a biological assay. In this assay, 2–4 units (U)/ml of murine
IFNβ yielded a 50% reduction in VLP infection, but sera has
an effect on the sensitivity of this assay so the calibration
provided in Fig. 6B consists of normal mouse serum (NMS)
containing murine IFNβ added to a final concentration of 0, 50
or 250 U/ml. IFN activity was measured in serum samples from
all mice harvested on the first 4 days of infection. The number
of mice that produced detectable levels of IFN in response to
WNV NS2A D73H infection (3 out of 12) was statistically
different from the number of mice (12 out of 12) that produced
IFN in response to wt WNV infection (Fisher's exact test;
p<0.0005, Fig. 6B). There was also a statistically significant
difference between the level of VLP neutralization detected in
sera in mice sacrificed 2 days post infection with WNV NS2A
D73H compared to wt WNV (t-test; p<0.001) and a trend
towards significance (t-test; p<0.06) for these same values
obtained with sera collected on day 4 post infection (Fig. 6B).
Taken together, these data indicate that a virus with a reduced
ability to replicate elicits a lower level of IFN in vivo.
Discussion
Eukaryotic cells employ several mechanisms to detect and
eliminate viral infection whereas viruses have evolved ways to
avoid, alter, delay or redirect the cell's innate immune responses.
Studying the interactions between WNRs and cells can reveal
information related to this complex interaction, which can result
either in cytopathology, cell death, or a persistent infection.
Here, we describe mutations observed afterWNR genomes were
forced to adapt to cell culture and the phenotypes of replicon and
viral genomes harboring some of these cell-adapted mutations.
Mice infected with WNV NS2A D73H produce a delayed
and decreased IFN response to infection compared to wt-
infected mice. This could be due to individual cells producing
little IFN in response to infection or be due to there being fewer
Fig. 6. Viremia and serum IFN levels in mice infected with 1×105 ffu of wt
WNV or WNV NS2A D73H. (A) Viremia in mice infected with either wt or
NS2A D73H WNV. Each plot point represents the data collected from one
mouse on the indicated day. The limit of detection for this assay is 33 ffu/ml.
Solid and dotted horizontal lines show the average titer for samples at that time
point for wt WNVandWNVNS2AD73H viruses, respectively. (B) IFN activity
detected in serum of mice infected with either wt or NS2A D73H WNV. Values
are expressed as percent inhibition of luciferase-VLP infection relative to wells
infected with these VLPs in the presence of NMS. Each plot point represents the
data collected from one mouse at the indicated day or treatment. Solid and dotted
horizontal lines show the mean titer for samples at that time point for wt and
WNV NS2A D73H viruses, respectively. The right side of this figure shows the
effect of murine IFNβ added to NMS at a final concentration of 50 U/ml or
250 U/ml within sera. The average of these two points is shown as a dashed
horizontal line. Pretreatment of selected samples showing a high inhibition of
VLP infection with anti-IFN blocked their activity, indicating that the inhibition
detected in this assay was due to IFN (results not shown). Significance for
difference between titers, as shown by the asterisk, was determined by two-
tailed, unpaired Student's t-test (*p<0.001).
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also unknown if cells infected with genomes harboring the cell-
adapted mutations described in this manuscript are more
sensitive to exogenous IFN treatment than wt-infected cells.
The ability of WNV NS2A D73H to either induce less IFN
production and/or cause cells to respond differently to
exogenous IFN compared to wt WNV is of interest and is
under further investigation. The attenuated phenotypes of WNVNS2A D73H and WNV NS2A M108K are similar to WNV-
MAD78 and therefore it is possible that our mutated lineage I
viruses would have a similar sensitivity to IFN as lineage II
viruses. On the other hand, it is possible that viruses that
replicate poorly would not produce viral products at levels high
enough to block STAT1 phosphorylation and all downstream
functions of ISGF3 signaling. If this were true, then cells
infected with these viruses would still be responsive to IFN,
which could lead to viral clearance from the cell and the animal
host. Consistent with these findings, we have shown that cell-
adapted WNR, which display low levels of replication, are
readily cleared by IFN treatment (Rossi et al., 2005), but the
individual cell line in which replicons persist can also influence
this interaction (Scholle and Mason, 2005).
The data presented in this manuscript support our hypothesis
that reduced replication is associated with a lack of replicon
cytopathogenicity. Here we show that WNRs and WNVs har-
boring cell adapted mutations within the NS2A and NS3 genes
are capable of reducing genome replication, reducing cy-
topathogenicity in vitro and allowing establishment of persistent
replication in cell culture compared to wt genomes.
In this study, more than half of the WNR genomes harvested
from replicon-bearing cell lines contained missense mutations in
the NS2A gene. Interestingly, others have reported that mu-
tations within the NS2A gene of flavivirus replicons appear to be
important for the establishment of noncytopathic persistent re-
plication inmammalian cells (Liu et al., 2004; Rossi et al., 2005).
Genomes harboring either NS2A D73H or NS2A M108K
mutations have high CFE values, replicate poorly and fail to
cause mortality in mice. In our hands,WNVandWNR harboring
the NS2A A30P mutation showed phenotypes similar to wt
WNV in most experiments. Although the NS2A A30P mutation
did not affect the ability of KUNV replicons to replicate in cell
culture, this mutation allowed replicons to readily form
antibiotic-resistant cell colonies: 17-fold greater than wt repli-
cons in BHK cells and approximately 50-fold greater than wt
replicons in HepG2 and HEK293 cells (Liu et al., 2004). When
the NS2A A30P mutation was introduced into WNR NS1-5
ET2AN, however, the CFE in Huh7 cells was only 4.7-fold
higher than wt replicons. In vitro, WNR C-eGFP-NS1-5 har-
boring NS2A A30P was reduced slightly in genome replication
early during infection but replicated similarly to wt replicons
after 24 hpi.WNVNS2AA30P also grew to a slightly lower titer
but produced large antigen-positive foci in Vero cells. Addi-
tionally, WNR NS1-5 NS2A A30P VLPs were able to induce
CPE in tissue culture. WNV NS2A A30P is lethal with a similar
LD50 to wt in 6-week-old outbred Swiss-Webster mice. Con-
versely, KUNVNS2AA30P is highly attenuated and reported to
be similar to in mice only 3 weeks old (Liu et al., 2006). These
results indicate that the phenotype of the NS2A A30P mutation
within KUNV is not the same as within a North AmericanWNV.
This disparity is likely due to other attenuating mutations in
KUNVand argues that the A30P mutation may be unsuitable for
use in generating an attenuated vaccine strain.
In NS3, we detected one sense mutation (G32G), one inser-
tion of three nucleotides (117K) and two mixed populations of
missense mutations and wt sequences (V57V/A and K107K/E).
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but since they occurred as mixed missense mutations within the
persistentWNR population and thus it seemed unlikely that their
phenotype would have a strong advantage to the establishment
of persistence in vitro (see discussion of NS4B E249G below).
WNR NS1-5 ET2AN 117Kins showed a noncytopathic phe-
notype and had a high CFE, but reverted to a wt phenotype
quickly when introduced into WNR C-eGFP-NS1-5 or WNV
genomes in cell culture. Replicon genomes with this mutation
had a selective advantage during the establishment of replicon-
bearing cell lines (under G418 selection) but were at a strong
disadvantage during genome replication in non-selective media
and were therefore not analyzed further in this study.
Surprisingly, no mutations were observed in the 5′ and 3′
UTRs, NS1, NS2B or NS5 that specifically altered genome
replication and yielded a cell-adapted phenotype. Genomes
harboring the NS4B E249G and NS5 P528H mutations had wt
phenotypes. Interestingly, the NS4B E249G mutation has been
observed in several natural WNV isolates (Davis et al., 2004;
Lanciotti et al., 2002). Naturally occurring viruses harboring the
NS4B E249G mutation produced small foci, were temperature
sensitive and not lethal in mice (Davis et al., 2004). However, a
NY99 WNV genetically engineered to only contain the NS4B
E249G mutation produced large antigen-positive foci, showed
no difference in growth kinetics in Vero cells to wt NY99 WNV
and were lethal for mice (C. T. Davis and A.D.T. Barrett, per-
sonal communication), consistent with the highly virulent wt
phenotype of WNV NS4B E249G described here. Recently, Shi
and coworkers reported the characterization of a C3H/He mouse
cell-adapted replicon based on a NY00 strain of WNV. During
adaptation, this WNR acquired the same NS4B E249Gmutation
that we observed, and genetically engineered WNR with this
mutation were shown to be twice as likely as the parental
replicon to produce antibiotic-resistant colonies in C3H/He and
BHK21 cells (Puig-Basagoiti et al., in press). Additionally, this
group reported that WNR NS4B E249G replicated more poorly
compared to wt replicons in C3H/He and BHK21 but not Vero
cells (Puig-Basagoiti et al., in press). Finally, Puig-Basagoiti et al.
showed that NY00WNVNS4BE249Gwas slightly less virulent
thanNY00WNVby footpad inoculation of 1000 plaque-forming
units in 6-week-old C3H/HeN mice (Puig-Basagoiti et al., in
press). These in vitro data correlate well with our data showing
that TX02 WNR with this same mutation produced a two-fold
higher CFE relative to the wt TX02 WNR. However, the in vivo
attenuating properties of the NS4B E249G mutation reported by
Shi and coworkers, differ from our data with a TX02 WNV
NS4B E249G mutant (Table 2) or work of Davis et al. with a
NY99 WNV NS4B E249G mutant (C.T. Davis and A.D.T.
Barrett, personal communication), which failed to demonstrate
an affect of this NS4B E249G mutation on LD50 values in i.p.-
inoculated outbred mice. The discrepancy among these in vivo
results might reflect the differences in WNV strains, mouse
strains, and/or inoculation routes employed in these studies.
It is unclear why the NS2A gene appears to be a hotspot for
cell-adapted mutations. If a reduction in replication alone were
important for establishing persistence, then it would be expected
that changes in the polymerase (NS5) or 3′ and 5′ UTRs couldhave produced a similar adapted phenotype. NS2A is one of
several flaviviral proteins that are believed to intercalate into the
ER membrane anchoring the RNA replication complex,
facilitating efficient genome replication (Lindenbach and Rice,
2001). Although the possibility that NS2A could coordinate
virion assembly (Kummerer and Rice, 2002; Liu et al., 2003)
and genome replication is of great interest, this activity is
unlikely to be relevant to the adaptation of WNR to persist in the
cell. However, NS2A's ability to cause changes in RNA
replication levels or changes in NS2A's ability to block IFN
signaling could directly influence WNR adaptation to persist in
vitro. Point mutations detected within NS2A reported here and
observed by others [in the laboratory propagated (Liu et al.,
2003, 2004) and natural WNV isolates (Beasley et al., 2005;
Lanciotti et al., 2002)] occur in linear amino acid sequences
within hydrophilic domains interspersed between long hydro-
phobic domains which are likely buried in the ER membrane.
Thesemutations could induce subtle changes in RNA replication
activity that might be harder to induce by point mutations in
soluble globular proteins such as helicases, proteases and
polymerases, helping to explain why NS2A appears to be a
hotspot for adaptive mutations. Changes in the UTRs that
produce an adapted phenotype might require large-scale
alterations, which might not be readily achievable by point
mutations.
Materials and methods
Cells, plasmids, viruses and VLPs
Vero, BHK, Huh7, Huh7 cells harboring WNRs, and BHK
packaging cells were maintained as previously described
(Fayzulin et al., 2006; Rossi et al., 2005). HeLa cells were
maintained in DMEMwith 10% FBS, 20 μg/ml gentamycin and
1% antibiotics. MEF, MEF RNase L−/− (Zhou et al., 1999) and
MEF STAT1−/− (Durbin et al., 1996) cells were grown in
DMEM with 5% FBS 20 μg/ml gentamycin and 1% antibiotics,
non-essential amino acids and sodium pyruvate.
Generation, characterization and manipulation of a WNV
infectious clone (in pACNR plasmid) and multiple WNRs
clones have been previously described (Fayzulin et al., 2006;
Rossi et al., 2005). One additional clone designated WNR C-
eGFP-NS1-5 was constructed to include the entire coding
sequence of C and eGFP between the structural and nonstruc-
tural genes. For increased stability, the WNV cDNA was also
transferred to a bacterial artificial chromosome plasmid (pBAC,
described in Suzuki et al., in press). All viruses used in this study
were recovered from BHK cells electroporated with in vitro
transcribed RNA [T7 MEGAscript (Ambion) supplemented
with 7-MeG cap analog (New England Biolabs)] obtained from
these pACNR-propagated or pBAC-propagated cDNA tem-
plates. Virus-like particles (VLPs) were produced as previously
described (Fayzulin et al., 2006). Supernatants containing VLPs
were harvested from electroporated packaging cells 2–7 days
post transfection with in vitro transcribed replicon RNA.
Schematic diagrams of all WNV or WNR constructs are
shown in Fig. 1.
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Total RNA was extracted from G418-resistant clones of
Huh7 cells bearing replicons by using either the Trizol LS
Reagent (Life Technologies) or RNaqueous kit (Ambion). This
RNA was used as a template for reverse transcription (ImProm
II, Promega) reactions using either random hexamers and/or
specific antisense primers that anneal at the end of the 3′ UTR
of WNV (5′ AGATCCTGTGTTCTCGCACC 3′). Fragments
of replicon cDNA amplified from these reactions by PCR
using WNV-specific primer pairs were gel purified and
sequenced by standard techniques (Protein Chemistry Core
Laboratory, UTMB). Mutations of interest were recreated by
overlap PCR mutagenesis (Higuchi et al., 1988) or obtained
from the PCR amplified cDNA fragments collected from
Huh7 replicon-bearing cells and were cloned into replicon-
encoding plasmids using standard recombinant DNA techni-
ques. All mutant cDNA plasmid clones were sequenced
through the PCR-amplified region to ensure no other missense
mutations were present and in vitro transcribed RNA from
these constructs was transfected into cells to ensure their
ability to replicate. A full-length clone with a large deletion in
the 3′ UTR of the virus (between nucleotides 43 and 388 of
the 3′ UTR) was also generated using similar methods. In
selected cases, fragments of cDNA were transferred to pBAC
encoding the full-length infectious clone cDNA to create
mutant viruses.
Immunohistochemical (IHC) staining of monolayers to detect
WNV antigen
Viral antigen was detected by immunohistochemistry using
a polyclonal mouse hyperimmune ascites fluid from WNV-
infected mice as previously described (Rossi et al., 2005). In
the cases where antigen staining was weak, the signal was
enhanced using a biotin-conjugated secondary antibody,
followed by streptavidin amplification (Vectastain ABC kit,
Vector Technologies).
Determination of CFE and expansion of G418-resistance
colonies
Colony-formation efficiency CFE was determined by
electroporating replicon RNA harboring the NPT gene (WNR
NS1-5 ET2AN; see Fig. 2) into Huh7 cells. An aliquot of these
cells was seeded in a 24-well plate, fixed and immunostained
48 h post electroporation to determine the number of pro-
ductively transfected cells. The remaining electroporated cells
were serially diluted into 6-well plates and 48 h after elec-
troporation, these cells were fed new growth media
supplemented with 33% conditioned media and 400 μg/ml
G418. This selective media was changed every 3 days for
2 weeks. Two weeks after electroporation, the cell monolayers
were stained with crystal violet and the antibiotic-resistant
colonies were counted. No colonies were detected in Huh7
cultures that were electroporated with no RNA and main-
tained under the same conditions. CFE was calculated as theratio of G418-resistant colonies to the number of positively
transfected cells.
Focus-formation assays and virus/VLP titration
All viruses were titrated on Vero cells except for samples
taken for the Huh7 growth curve (see Fig. 5, Panel B), which
were titrated on Huh7 cells. Monolayers in 96-well plates were
infected with virus dilutions, overlaid with 0.6% tragacanth-
containing media, incubated for 24–36 h and processed by IHC.
VLPs were titrated in a similar manner except these cultures
were not overlaid with tragacanth. Virus titration of mouse sera
was performed as described above except in 24-well plates and
incubated for 2–3 days prior to fixation and IHC staining. The
numbers of infectious foci (or cells in the case of VLPs) were
then used to determine the titer in focus forming units (ffu; virus)
or in infectious units (iu; VLPs) per milliliter.
Flow cytometry
Vero cells were infected with VLPs bearing eGFP (WNR C-
eGFP-NS1-5; see Fig. 2) at aMOI of 1, incubated for 1 h to allow
for VLP adsorption, washed, refed with growth media and incu-
bated for the indicated times. At harvest, cells were trypsinized,
resuspended in PBS supplemented with 1% fetal calf serum and
analyzed by flow cytometry (Flow Cytometry and Cell Sorting
Core Laboratory, UTMB). Histograms of eGFP fluorescence at
emission 530 nm of the viable cell population was determined by
standard techniques and FloJo software (version 8.1) was used to
calculate GM eGFP fluorescence for each sample.
MTT cell viability assays
Cell viability was measured by growing cells for 3 h in
medium containing 1 mg/ml of 3,[4.5-dimethyltriazol-2-yl]-2,5-
diphenyltetrazolium bromide (MTT) and measuring the amount
of MTT converted to an insoluble product as previously des-
cribed (Rossi et al., 2005).
In vivo assessment of attenuation
Groups of 5 four-week-old female Swiss-Webster mice
(Harlan) were inoculated i.p. with virus diluted in PBS sup-
plemented with 10% FBS. Mice were observed daily for 15 days
for signs of illness or death. Moribund mice were humanely
euthanized to reduce their suffering and the next day was
recorded as the day of death in compliance with UTMB Animal
Care and Use requirements. LD50 values were calculated for
each virus (Reed and Meunch, 1938).
Serum and brain tissue were collected from all euthanized
animals and stored frozen (−80 °C). One of the frozen brain
hemispheres was thawed in 1 ml L15 media and physically
disrupted using a homogenizer (4 min at 30 cycles/s) and a steel
ball (GlenMills Inc.). Supernatant was collected after clarifica-
tion by centrifugation of homogenized brain tissue and stored at
−80 °C. For analysis of progeny viral genomes in infected mice,
Vero cells were infected with 1/10th the volume of the brain
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RNA was isolated, viral genomes were amplified by RT-PCR
and sequenced as described above.
Neutralization assay
Serum was collected from all surviving mice 1 month after
challenge and tested for the presence of neutralizing WNVanti-
bodies. Sera were heat inactivated at 56 °C for 30 min, diluted
two-fold, incubated at 37 °C for 2 h with approximately 100 ffu
of WNV VLPs containing a replicon encoding the full C gene
and NS1-5 (R. Fayzulin and P.W.Mason, unpublished data), and
then plated on Vero cells seeded in 96-well clear-wall plates.
Twenty-four hours later, cells were fixed and immunostained,
and antigen-positive cells were counted and used to determine
the serum dilution that produced an 80% reduction in VLP-
positive cells. In this assay, NMS collected from age-matched
outbred mice displayed an 80% reduction in antigen-positive
cells at a dilution of 1/80.
Detecting virus and IFN produced in mice
Four-week-old female Swiss-Webster mice were inoculated
i.p. with 1×105 ffu of NS2A D73H WNV or wt WNV. Three
mice/virus were humanely euthanized days 1–6 post inocula-
tion and serum was collected as described above. Virus was
detected by titration on Vero cells as described above.
IFN levels were measured using a bioassay. Serum samples
were diluted with three volumes of 1× MEM without serum or
phenol red and treated with UV light (254 nm, 4W, 10 cm) for
10 min to inactivate infectious virus. The UV-inactivated
samples were then further diluted four-fold and used to inoculate
MEF monolayers in 96-well, black-wall plates. Plates were
incubated overnight (14–18 h), the serumwas then aspirated and
the monolayers were infected with VLPs containing WNR C-
luc-NS1-5 (see Fig. 2). Twenty-four hours after VLP infection,
cells were lysed by the addition of lysis buffer containing D-
luciferin and ATP (SteadyGlo, Promega) and after a 5-min
incubation, the plates were read on a luminometer. Percent
inhibition was determined by normalizing photon/s of each
sample to a sample that contained the same concentration of
NMS alone. NMS containing a known amount of murine IFNβ
(NIH standard; 0, 50 or 250 U/ml final concentration) were
analyzed in parallel to show the percent inhibition of infection
produced in mouse sera containing known IFN concentrations.
The NIH standard murine IFNβ produced from L-cells and
antibody to type I IFN were obtained from the NIAID Reference
Reagent Repository, which is operated by KamTek, Inc. or
Braton Biotech, Inc., respectively. Anti-type I IFNwas also used
to determine the specificity of our inhibition by preincubating
serum with this antibody prior to analysis.
Statistical analyses
Comparisons among samples within a group were made
using a two-tailed, unpaired Student's t-test. Incidence data
were compared by Fisher's exact test.Acknowledgments
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